BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16504826)

  • 1. New treatments for antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Rheum Dis Clin North Am; 2006 Feb; 32(1):129-48, x. PubMed ID: 16504826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of refractory anti-phospholipid syndrome.
    Scoble T; Wijetilleka S; Khamashta MA
    Autoimmun Rev; 2011 Sep; 10(11):669-73. PubMed ID: 21558021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in antiphospholipid syndrome.
    Sciascia S; Khamashta MA; D'Cruz DP
    Curr Opin Rheumatol; 2014 May; 26(3):269-75. PubMed ID: 24646948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of antiphospholipid syndrome.
    Gerosa M; Meroni PL; Erkan D
    Curr Opin Rheumatol; 2016 Jan; 28(1):51-9. PubMed ID: 26599382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing antiphospholipid antibodies and antiphospholipid syndrome in children.
    Kamat AV; D'Cruz DP; Hunt BJ
    Haematologica; 2006 Dec; 91(12):1674-80. PubMed ID: 17145604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
    Sanna G; D'Cruz D; Cuadrado MJ
    Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Therapies in Antiphospholipid Syndrome.
    Andrade D; Tektonidou M
    Curr Rheumatol Rep; 2016 Apr; 18(4):22. PubMed ID: 26995745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
    Bucciarelli S; Espinosa G; Cervera R
    Lupus; 2009 Sep; 18(10):905-12. PubMed ID: 19671791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid syndrome in pregnancy--actual therapeutic methods].
    Matusiak-Kita M; Murawski M; Gryboś M
    Wiad Lek; 2008; 61(10-12):273-6. PubMed ID: 19323068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ped-APS Registry: the antiphospholipid syndrome in childhood.
    Avcin T; Cimaz R; Rozman B;
    Lupus; 2009 Sep; 18(10):894-9. PubMed ID: 19671789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New alternatives for the treatment of antiphospholipid syndrome. A literature review].
    Ibáñez S; Iruretagoyena M; Gutiérrez MA
    Rev Med Chil; 2013 Aug; 141(8):1041-8. PubMed ID: 24448861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
    Kisiel E; Kryczka W
    Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.